# Brainsway DTMS for Treatment of MDD Using iTBS

> **NCT04679753** · PHASE4 · COMPLETED · sponsor: **Brainsway** · enrollment: 177 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DEVICE:** Brainsway DTMS with intermittent Theta Burst Stimulation (iTBS)
- **DEVICE:** Brainsway DTMS with High Frequency (HF) Stimulation

## Key facts

- **NCT ID:** NCT04679753
- **Lead sponsor:** Brainsway
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2020-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04679753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04679753, "Brainsway DTMS for Treatment of MDD Using iTBS". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04679753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*